Ventas Inc. logo

Ventas Inc. (VTR)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
79. 04
-1.09
-1.3603%
$
41.04B Market Cap
2,467.5 P/E Ratio
3.62% Div Yield
4.43M Volume
0 Eps
$ 80.13
Previous Close
Add Transaction
Day Range
78.63 81.39
Year Range
61.76 91.06
Want to track VTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ventas Q2 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises

Ventas Q2 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises

VTR's Q2 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.

Zacks | 10 months ago
Ventas, Inc. (VTR) Q2 2025 Earnings Call Transcript

Ventas, Inc. (VTR) Q2 2025 Earnings Call Transcript

Ventas, Inc. (NYSE:VTR ) Q2 2025 Earnings Conference Call July 31, 2025 10:00 AM ET Company Participants Bill Grant - Senior Vice President of Investor Relations Debra A. Cafaro - Chairman & CEO J.

Seekingalpha | 10 months ago
Ventas (VTR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Ventas (VTR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Ventas (VTR) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 10 months ago
Ventas (VTR) Beats Q2 FFO and Revenue Estimates

Ventas (VTR) Beats Q2 FFO and Revenue Estimates

Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.87 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to FFO of $0.8 per share a year ago.

Zacks | 10 months ago
Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Ventas (VTR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Zacks | 10 months ago
What's in the Offing for Ventas Stock This Earnings Season?

What's in the Offing for Ventas Stock This Earnings Season?

While VTR's Q2 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.

Zacks | 10 months ago
Ventas (VTR) Could Be a Great Choice

Ventas (VTR) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

Zacks | 10 months ago
Ventas Stock Gains 11.6% in 6 Months: Will the Trend Last?

Ventas Stock Gains 11.6% in 6 Months: Will the Trend Last?

VTR is likely to gain from an aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio.

Zacks | 10 months ago
Ventas Looks Bullish

Ventas Looks Bullish

Ventas' recent dividend increase and international exposure position it well for future growth, despite its current yield lagging behind Treasuries. Lower interest rates and management's strong execution could make VTR's dividend more attractive and support further upside. Technical analysis shows bullish price action, improving momentum, institutional support, and rising relative strength vs. the S&P 500.

Seekingalpha | 10 months ago
Here's Why Ventas (VTR) is a Strong Momentum Stock

Here's Why Ventas (VTR) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 11 months ago
Ventas (VTR) Could Be a Great Choice

Ventas (VTR) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

Zacks | 11 months ago
Ventas: Guidance Increased As Occupancy Continues To Improve

Ventas: Guidance Increased As Occupancy Continues To Improve

Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple net properties. The company increased its FFO guidance as senior housing continues to benefit from higher occupancy and improved margins. Indeed, I estimate that Ventas may see a NOI boost as high as $190 million should robust senior housing performance continue.

Seekingalpha | 11 months ago
Loading...
Load More